Integrating Pharmacology and Microbial Network Analysis with Experimental Validation to Reveal the Mechanism of Composite Sophora Colon-Soluble Capsule against Ulcerative Colitis

<div>Candidate bioactive components in CSCC. The 119 candidate bioactive components (SFR = 30; IN = 7; BS = 6; RS = 4; LR = 72) of CSCC were determined with DL index ≥0.18, OB ≥ 30%, and Caco-2 ≥ 0.4.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Integrating Pharmacology and Microbial Network Analysis with Experimental Validation to Reveal the Mechanism of Composite Sophora Colon-Soluble Capsule against Ulcerative Colitis 

Figure 2 | Integrating Pharmacology and Microbial Network Analysis with Experimental Validation to Reveal the Mechanism of Composite Sophora Colon-Soluble Capsule against Ulcerative Colitis 